Press Releases

Date	Title	Company
11-Jun-2021	Pharmaxis Announces Progression of Clinical Trial in Bone Marrow Cancer	Pharmaxis
11-Jun-2021	U.S. Food and Drug Administration Approves New Formulation of Epclusa®, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C	Gilead
11-Jun-2021	New Roche data for Evrysdi show improved motor function in pre-symptomatic babies after one year and confirm safety profile in previously treated people with spinal muscular atrophy (SMA)	Roche
11-Jun-2021	Sanofi provides update on Aubagio® (teriflunomide) submission for children and adolescents with relapsing-remitting multiple sclerosis in the U.S.	Sanofi
11-Jun-2021	New pivotal data at EHA 2021 reinforces sutimlimab as a first-in-class investigational C1s inhibitor with the potential to be the first approved treatment for hemolysis in people with CAD, a serious and chronic autoimmune hemolytic anemia	Sanofi
11-Jun-2021	New Data Shows AbbVie's VENCLYXTO®/VENCLEXTA® Fixed Duration Combination Demonstrates Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients after Three Years off Treatment	AbbVie
11-Jun-2021	Moderna Files for Emergency Use Authorization for its COVID-19 Vaccine in Adolescents in the United States	Moderna
11-Jun-2021	Three in four people with a learning disability receive NHS annual health check	NHS England
11-Jun-2021	NHS ahead of target in recovery of elective care, and mental health services back to pre-pandemic levels	NHS England
11-Jun-2021	Healthcare Fraud Analytics Market: Emergence of Social Media	MarketsandMarkets
11-Jun-2021	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
11-Jun-2021	Cancer Diagnostics Market worth $26.6 billion - Covid -19 Impact and Growing focus on personalized medicine	MarketsandMarkets Research Private Ltd.
11-Jun-2021	Vertex and CRISPR Therapeutics Present New Data in 22 Patients With Greater Than 3 Months Follow-Up Post-Treatment With Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at European Hematology Association Annual Meeting	Businesswire
11-Jun-2021	Caelum and Alexion Present Additional Phase 2 Data Reinforcing Safety and Tolerability of CAEL-101 in AL Amyloidosis at the European Hematology Association Congress 2021	Businesswire
11-Jun-2021	Bristol Myers Squibb and Acceleron Present First Results from Phase 2 BEYOND Study of Reblozyl® (luspatercept-aamt) in Adults with Non-Transfusion Dependent (NTD) Beta Thalassemia	Businesswire
11-Jun-2021	BeiGene Presents ALPINE Results at EHA2021 Demonstrating Both Efficacy and Safety Advantages of BRUKINSA® (Zanubrutinib) in Head-to-Head Comparison to Ibrutinib in Chronic Lymphocytic Leukemia	Businesswire
11-Jun-2021	Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure	Businesswire
11-Jun-2021	BeiGene Presents Long-Term Efficacy and Safety Results from Three Pivotal Trials of BRUKINSA® (Zanubrutinib) and Tislelizumab at EHA2021	Businesswire
11-Jun-2021	Celyad Oncology Presents Preliminary Data from Phase 1 IMMUNICY-1 Trial of shRNA-based Allogeneic CAR T Candidate CYAD-211 in Relapsed/Refractory Multiple Myeloma at the European Hematology Association Virtual Congress	Businesswire
11-Jun-2021	Elderly Care Market Size, Growth 2021 Industry & Technological Innovation: Major Players Exceptional Living Centers, Amedisys, Living Assistance Services, ElderCareCanada, LHC Group, Encompass Health Corporation, Extendicare	The Wire Times